DJIA 18,024.06 183.54 1.03%
NASDAQ 5,005.39 63.97 1.29%
S&P 500 2,108.29 22.78 1.09%
market minute promo

GlaxoSmithKline (NYSE: GSK)



company name or ticker
Company Photos
(Click to zoom)

Veeva (VEEV) OpenKey: A Key to Customer Data Referencing - Analyst Blog

Is It Time for GlaxoSmithKline plc to Change Management?

GlaxoSmithKline's share price has stagnated under CEO Andrew Witty. Is it time for a change?

Sector Leaders Hone 53.52% Edge As Highest Yield, Lowest Price, March Dividend Dogs

9 Top Sector Dividend Dogs Dish Out 22% To 47% March Upsides

Stocks to Cure What Ails on World TB Day - Analyst Blog

GlaxoSmithKline (GSK) Moving On Heavy Pre-Market Trading

Pre-Market Most Active for Mar 23, 2015 : STO, GSK, GILD, AAPL, VRTX, IMGN, RDS/B, QQQ, FB, RDS/A,

Pre-Market Most Active for Mar 23, 2015 : STO, GSK, GILD, AAPL, VRTX, IMGN, RDS/B, QQQ, FB, RDS/A, SDRL, NVS

GSK And Theravance: Implications Of The Advisory Panel Decision

Why Pfizer Inc. Isn't Built to Last

Pfizer may be about to break up. Here's what investors need to know.

Theravance/Glaxo's Breo Ellipta Gets Mixed FDA Panel View - Analyst Blog

See More Articles...